At 72 months, the PFS was 91.1% for CR and 55.8% for non-CR, indicating CR superior regarding long-term local tumor control in VHL-associated cases, with significantly worse outcomes observed in those with non-CR (see Figure 2B). Here, VHL is linked to neoplasm.